Kuchenbaecker KB, Hopper JL, Barnes DR, et al. Risks of breast, ovarian, and contralateral breast cancer for BRCA1 and BRCA2 mutation carriers. JAMA. 2017;317:2402–16.

Article  CAS  PubMed  Google Scholar 

Tozaki M, Nakamura S. Current status of breast cancer screening in high-risk women in Japan. Breast Cancer. 2021;28:1181–7.

Article  PubMed  Google Scholar 

Nakamura S, Takahashi M, Tozaki M, et al. Prevalence and diferentiation of hereditary breast and ovarian cancers in Japan. Breast Cancer. 2015;22:462–8.

Article  PubMed  Google Scholar 

Murakami W, Tozaki M, Nakamura S, et al. The clinical impact of MRI screening for BRCA mutation carriers: the first report in Japan. Breast Cancer. 2019;26:552–61.

Article  PubMed  Google Scholar 

Schrading S, Kuhl CK. Mammographic, US and MR imaging phenotypes of familial breast cancer. Radiology. 2008;246:58–70.

Article  PubMed  Google Scholar 

Riedl C, Luft N, Bernhart C, et al. Triple-modality screening trial for familial breast cancer underlines the importance of magnetic resonance imaging and questions the role of mammography and ultrasound regardless of patient mutation status, age, and breast density. J Clin Oncol. 2015;33:1128–35.

Article  PubMed  PubMed Central  Google Scholar 

Sridharan A, Eisenbrey JR, Dave JK, et al. Quantitative nonlinear contrast-enhanced ultrasound of the breast. AJR Am J Roentgenol. 2016;207:274–81.

Article  PubMed  PubMed Central  Google Scholar 

Wan C, Du J, Fang H, et al. Evaluation of breast lesions by contrast-enhanced ultrasound: qualitative and quantitative analysis. Eur J Radiol. 2012;81:e444–50.

Article  PubMed  Google Scholar 

Janu E, Krikavova L, Little J, et al. Prospective evaluation of contrast-enhanced ultrasound of breast BI-RADS 3–5 lesions. BMC Med Imaging. 2020;20:66.

Article  PubMed  PubMed Central  Google Scholar 

Kanazawa S, Mitsuzuka Y, Ogata H, et al. Comparison of CEUS with enhanced MR-mammography in patients with breast cancer. Ultrasound Med Biol. 2011;37:S47.

Article  Google Scholar 

Sparano JA, Gray RJ, Makower DF, et al. Adjuvant chemotherapy guided by a 21-gene expression assay in breast cancer. N Engl J Med. 2018;378:111–21.

Article  Google Scholar 

Kalinsky K, Barlow WE, Gralow JR, et al. 21-gene assay to inform chemotherapy benefit in node-positive breast cancer. N Engl J Med. 2021;385:2336–47.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gramiak R, Shah PM, Kramer DH. Ultrasound cardiography: contrast studies in anatomy and function. Radiology. 1969;92:939–47.

Article  CAS  PubMed  Google Scholar 

Meltzer RS, Tickner EG, Sahines TP, et al. The source of ultrasound contrast effect. J Clin Ultrasound. 1980;8:121–7.

Article  CAS  PubMed  Google Scholar 

Matsuda Y, Yabuuchi I. Hepatic tumors: US contrast enhancement with CO2 microbubbles. Radiology. 1986;161:701–5.

Article  CAS  PubMed  Google Scholar 

Kudo M, Tomita S, Tochio H, et al. Hepatic nodular hyperplasia: Specific findings at dynamic contrast-enhanced US with carbon dioxide microbubbles. Radiology. 1991;179:377–82.

Article  CAS  PubMed  Google Scholar 

Kudo M, Tomita S, Tochio H, et al. Small hepatocellular carcinoma: diagnosis with US angiography with intraarterial CO2 microbubbles. Radiology. 1992;182:155–60.

Article  CAS  PubMed  Google Scholar 

Nomura Y, Matsuda Y, Yabuuchi I, et al. Hepatocellular carcinoma in adenomatous hyperplasia: detection with contrast-enhanced US with carbon dioxide microbubbles. Radiology. 1993;187:353–6.

Article  CAS  PubMed  Google Scholar 

Matsuda Y, Ito T, Oguchi Y, et al. Rationale of surgical management for recurrent hepatocellular carcinoma. Ann Surg. 1993;217:28–34.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Matsuda Y, Yabuuchi I, Ito T, et al. Classification of ultrasonographic images of hepatocellular carcinoma using galactose-based contrast agent: relation between image patterns and histologic features. J Med Ultrason. 2004;31:111–20.

Article  Google Scholar 

Moriyasu F, Itoh K. Efficacy of perflubutane microbubble–enhanced ultrasound in the characterization and detection of focal liver lesions: phase 3 multicenter clinical trial. AJR Am J Roentgenol. 2009;193:86–95.

Article  PubMed  Google Scholar 

Sontum PC. Physicochemical characteristics of Sonazoid, a new contrast agent for ultrasound imaging. Ultrasound Med Biol. 2008;34:824–33.

Article  PubMed  Google Scholar 

Watanabe R, Matsumura M, Munemasa T, et al. Mechanism of hepatic parenchyma-specific contrast of microbubble-based contrast agent for ultrasonography microscopic studies in rat liver. Invest Radiol. 2007;42:643–51.

Article  CAS  PubMed  Google Scholar 

Miyamoto Y, Ito T, Takada E, et al. Phase II clinical study of DD-723 (perflubutane): dose–response study in patients with breast tumors. J Med Ultrason. 2012;39:79–86.

Article  Google Scholar 

Miyamoto Y, Ito T, Takada E, et al. Efcacy of sonazoid (Perfubutane) for contrast-enhanced ultrasound in the diferentiation of focal breast lesions: phase 3 multicenter clinical trial. AJR Am J Roentgenol. 2014;202:W400–7.

Article  PubMed  Google Scholar 

Kim TK. Contrast-enhanced us incorporating Kuppfer-phase findings for the diagnosis of hepatocellular carcinoma. Radiology. 2023;308:e231494.

Article  PubMed  Google Scholar 

Minami Y, Kudo M. Contrast-enhanced ultrasonography with Sonazoid in hepatocellular carcinoma diagnosis. Hepatoma Res. 2020;6:46.

CAS  Google Scholar 

Lee JY, Minami Y, Choi BI, et al. The AFSUMB consensus statements and recommendations for the clinical practice of contrast-enhanced ultrasound using Sonazoid. Ultrasonography. 2020;39:191–220.

Article  PubMed  PubMed Central  Google Scholar 

Minami Y. Understanding the differences between Japanese and U.S. guidelines on clinical practice for contrast-enhanced ultrasound of the liver. J Med Ultrason. 2023;50:1–3.

Article  Google Scholar 

Kudo M, Ueshima K, Osaki Y, et al. B-Mode ultrasonography versus contrast-enhanced ultrasonography for surveillance of hepatocellular carcinoma: a prospective multicenter randomized controlled trial. Liver Cancer. 2019;8:271–80.

Article  PubMed  PubMed Central  Google Scholar 

Arita J, Hasegawa K, Takahashi M, et al. Correlation between contrast-enhanced intraoperative ultrasound using Sonazoid and histologic grade of resected hepatocellular carcinoma. AJR Am J Roentgenol. 2011;196:1314–21.

Article  PubMed  Google Scholar 

Arita J, Takahashi M, Hata S, et al. Usefulness of contrast-enhanced intraoperative ultrasound using Sonazoid in patients with hepatocellular carcinoma. Ann Surg. 2011;254:992–9.

Article  PubMed  Google Scholar 

Zhang Q, Liang X, Zhang Y, et al. A review of contrast-enhanced ultrasound using SonoVue® and Sonazoid™ in non-hepatic organs. Eur J Radiol. 2023;167:111060.

Article  PubMed  Google Scholar 

Kang HJ, Lee JM, Kim SW. Sonazoid-enhanced ultrasonography for noninvasive imaging diagnosis of hepatocellular carcinoma: special emphasis on the 2022 KLCA-NCC guideline. Ultrasonography. 2023;42:479–89.

Article  PubMed  PubMed Central  Google Scholar 

Morin SH, Lim AK, Cobbold JF, et al. Use of second generation contrast-enhanced ultrasound in the assessment of focal liver lesions. World J Gastroenterol. 2007;13:5963–70.

Article  PubMed